India to Sri Lanka Pharmaceutical Export
Bilateral Trade Intelligence · $433.1M Total Trade · 473 Exporters · 850 Buyers · DGFT Verified · Updated March 2026
India exported $433.1M worth of pharmaceutical formulations to Sri Lanka across 21,887 verified shipments, sourced from 473 Indian exporters supplying 850 Sri Lanka buyers. The top exporters are CIPLA LIMITED ($57.0M) and SANOFI INDIA LIMITED ($38.8M). The leading products are Rifampicin ($15.9M) and Amoxicillin ($5.7M). Average shipment value: $19.8K.
Top Pharmaceutical Formulations — India to Sri Lanka
| # | Formulation | Value | Share |
|---|---|---|---|
| 1 | Pharmaceutical Products Daonil 5mg Tablets (6685 Packs 20x30 ), Generic Name Gl… | $37.0M | 8.5% |
| 2 | Rifampicin 150 MG / Isoniazid 75 MG / Ethambutol Hydrochloride 275 MG Tablets.… | $15.9M | 3.7% |
| 3 | Moxol-500 (amoxicillin Capsules BP 500 M | $5.7M | 1.3% |
| 4 | Capsules.gabanin 100 (gabapentin Capsules USP | $5.6M | 1.3% |
| 5 | Rifampicin Capsules BP 150mg. (10x10's)(3887 Pack) | $5.0M | 1.2% |
| 6 | Tablets.ranosin (ranolazine Extended Release | $5.0M | 1.2% |
| 7 | Tablets.tiglor 3x | $4.8M | 1.1% |
| 8 | Zaart 50 Tablets . (inv.qty.12460 Pack 10x10s=1246000 ) | $4.7M | 1.1% |
| 9 | Cephadex 500 Capsules . (inv.qty.7140 Pack 10x10s=714000 ) | $4.1M | 0.9% |
| 10 | Deplus 2000 Tablets (vitamin D3 2000 Iu) | $4.0M | 0.9% |
| 11 | Cephast 500mg | $3.9M | 0.9% |
| 12 | Cephadex 500 Capsules . (inv.qty.6480 Pack 10x10s=648000 ) | $3.7M | 0.9% |
| 13 | Chlorpheniramine Maleate Tablets 4 MG (1 | $3.6M | 0.8% |
| 14 | Genimet 500 | $3.3M | 0.8% |
| 15 | Capsules.gabanin 300 (gabapentin Capsules USP | $2.7M | 0.6% |
India exports 20+ pharmaceutical formulations to Sri Lanka with a combined trade value of $433.1M. Key products include Rifampicin ($15.9M), Amoxicillin ($5.7M), Gabapentin ($5.6M), Losartan ($4.7M), Cephalexin ($4.1M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 21,887 verified Indian Customs (DGFT) shipment records.
Top Pharmaceutical Products — India to Sri Lanka Trade Routes
These are the top pharmaceutical products exported from India to Sri Lanka, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Sri Lanka buyers, regulatory requirements, and logistics for that specific product corridor. Products include Rifampicin ($15.9M), Amoxicillin ($5.7M), Gabapentin ($5.6M), Losartan ($4.7M), Cephalexin ($4.1M) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.
Top Indian Exporters to Sri Lanka
473 Indian pharmaceutical companies export finished formulations to Sri Lanka. Leading exporters include Cipla Limited, Sanofi India Limited, Sun Pharmaceutical Industries Limited, Sterling Lab,. The top exporter accounts for 13.2% of total India–Sri Lanka pharma exports. Source: Indian Customs (DGFT).
Top Sri Lanka Buyers from India
850 companies in Sri Lanka import pharmaceutical formulations from India. Top buyers include Breathefree Lanka Pvt Ltd, A,baur & Co,(pvt,) Ltd, Sunshine Healthcare Lanka Limited, M/s.pharma Associates. The largest buyer accounts for 12.5% of India–Sri Lanka pharma imports. Source: Indian Customs (DGFT).
Port Analysis — India to Sri Lanka Pharmaceutical Shipments
Indian Export Ports
Sri Lanka Import Ports
Trade Statistics
Other Destinations
Product Routes
FAQ — India to Sri Lanka Pharmaceutical Trade
What is the total value of India's pharmaceutical export to Sri Lanka?
India exported pharmaceuticals worth $433.1M to Sri Lanka across 21,887 verified shipments.
Who are the top Indian pharmaceutical exporters to Sri Lanka?
1. CIPLA LIMITED — $57.0M. 2. SANOFI INDIA LIMITED — $38.8M. 3. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $29.2M. Total: 473 suppliers.
Which companies in Sri Lanka import pharmaceuticals from India?
1. BREATHEFREE LANKA PVT LTD — $53.9M. 2. A,BAUR & CO,(PVT,) LTD — $37.1M. 3. SUNSHINE HEALTHCARE LANKA LIMITED — $25.3M. 850 buyers total.
What pharmaceutical products does India export most to Sri Lanka?
1. Pharmaceutical Products Daonil 5mg Tablets (6685 Packs 20x30 ), Generic Name Gl… ($37.0M, 8.5%); 2. Rifampicin 150 MG / Isoniazid 75 MG / Ethambutol Hydrochloride 275 MG Tablets.… ($15.9M, 3.7%); 3. Moxol-500 (amoxicillin Capsules BP 500 M ($5.7M, 1.3%); 4. Capsules.gabanin 100 (gabapentin Capsules USP ($5.6M, 1.3%); 5. Rifampicin Capsules BP 150mg. (10x10's)(3887 Pack) ($5.0M, 1.2%)
Which ports handle pharmaceutical shipments from India to Sri Lanka?
Export: CHENNAI AIR, NHAVA SHEVA SEA (INNSA1), DELHI AIR, NHAVA SHEVA SEA, JNPT/ NHAVA SHEVA SEA. Import: Colombo, COLOMBO, Singapore, Ratmalana Apt-Colomb, Colombia.
Why does Sri Lanka import pharmaceuticals from India?
India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $433.1M corridor reflects quality compliance and pricing advantages.
What certifications do Indian pharmaceutical exporters need to supply Sri Lanka?
WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.
What is the average shipment value for India to Sri Lanka pharmaceutical trade?
$19.8K per consignment across 21,887 shipments.
How many Indian pharmaceutical companies export to Sri Lanka?
473 Indian companies. Largest: CIPLA LIMITED with $57.0M.
How can I find verified Indian pharmaceutical suppliers for Sri Lanka?
TransData Nexus covers 473 active exporters with shipment history and trade values at transdatanexus.com.
Unlock the Full India to Sri Lanka Pharmaceutical Export Dataset
Access complete shipment records, supplier intelligence, buyer histories, and price analytics for all 21,887 shipments.
Official References & Regulatory Resources
- WHO Essential Medicines List
- CDSCO India
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
- 2.Country Matching: Shipments to Sri Lanka identified using destination country codes from customs declarations.
- 3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
- 4.Coverage: 21,887 verified shipments from 473 Indian exporters to 850 Sri Lanka buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
473 Exporters
850 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists